Imperva (IMPV) Upgraded to “Overweight” by Piper Jaffray Companies

Imperva (NASDAQ:IMPV) was upgraded by equities researchers at Piper Jaffray Companies from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Friday, MarketBeat reports. The firm currently has a $52.00 price objective on the software maker’s stock. Piper Jaffray Companies’ target price would suggest a potential upside of 11.71% from the stock’s previous close.

IMPV has been the subject of a number of other research reports. BidaskClub lowered shares of Imperva from a “hold” rating to a “sell” rating in a research report on Wednesday, December 27th. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price for the company in a research report on Tuesday, October 24th. Morgan Stanley reiterated an “underweight” rating and issued a $39.00 target price on shares of Imperva in a research report on Thursday, November 9th. Stifel Nicolaus reiterated a “hold” rating and issued a $47.00 target price (down previously from $50.00) on shares of Imperva in a research report on Thursday, November 9th. Finally, Evercore ISI set a $56.00 target price on shares of Imperva and gave the company a “buy” rating in a research report on Thursday, October 19th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $52.93.

Imperva (NASDAQ IMPV) traded up $4.50 during trading on Friday, hitting $46.55. 2,138,319 shares of the stock traded hands, compared to its average volume of 271,353. The company has a market capitalization of $1,430.29, a price-to-earnings ratio of 68.46 and a beta of 1.79. Imperva has a fifty-two week low of $37.17 and a fifty-two week high of $52.40.

Imperva (NASDAQ:IMPV) last released its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, topping the consensus estimate of $0.27 by $0.13. The business had revenue of $91.10 million during the quarter, compared to analyst estimates of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. The company’s quarterly revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 earnings per share. equities analysts predict that Imperva will post -0.82 earnings per share for the current year.

Large investors have recently bought and sold shares of the company. SG Americas Securities LLC bought a new position in shares of Imperva during the 3rd quarter valued at about $134,000. First Quadrant L P CA bought a new position in shares of Imperva during the 3rd quarter valued at about $136,000. Ameritas Investment Partners Inc. boosted its position in shares of Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares in the last quarter. Amalgamated Bank bought a new position in shares of Imperva during the 2nd quarter valued at about $206,000. Finally, Principal Financial Group Inc. bought a new position in shares of Imperva during the 2nd quarter valued at about $223,000. Institutional investors own 96.61% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/02/10/imperva-impv-upgraded-to-overweight-by-piper-jaffray-companies.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply